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ABSTRACT Themucosalepitheliumistheinitialtargetforrespiratorypathogensofalltypes.WhiletypeIinterferon(IFN)signal-
ingistraditionallyassociatedwithantiviralimmunity,wedemonstratethattheextracellularbacterialpathogen Streptococcus
pneumoniaeactivatesthetypeIIFNcascadeinairwayepithelialanddendriticcells.Thisresponseisdependentuponthepore-
formingtoxinpneumolysin.PneumococcalDNAactivatesIFN-expressionthroughaDAI/STING/TBK1/IRF3cascade.
Tlr4/,Myd88/,Trif/,andNod2/mutantmicehadnoimpairmentoftypeIIFNsignaling.InductionoftypeIIFNsig-
nalingcontributestotheeradicationofpneumococcalcarriage,asIFN-/receptornullmicehadsigniﬁcantlyincreasednasal
colonization with S. pneumoniae compared with that of wild-type mice. These studies suggest that the type I IFN cascade is a
centralcomponentofthemucosalresponsetoairwaybacterialpathogensandisresponsivetobacterialpathogen-associated
molecularpatternsthatarecapableofaccessingintracellularreceptors.
IMPORTANCE The bacterium Streptococcus pneumoniae is a leading cause of bacterial pneumonia, leading to upwards of one mil-
liondeathsayearworldwideandsigniﬁcanteconomicburden.Althoughitisknownthatantibodyiscriticalforefﬁcientphago-
cytosis,itisnotknownhowthispathogenissensedbythemucosalepithelium.Wedemonstratethatthisextracellularpathogen
activatesmucosalsignalingtypicallyactivatedbyviralpathogensviathepneumolysinporetoactivateintracellularreceptors
and the type I interferon (IFN) cascade. Mice lacking the receptor to type I IFNs have a reduced ability to clear S. pneumoniae,
suggestingthatthetypeIIFNcascadeiscentraltothemucosalclearanceofthisimportantpathogen.
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T
heairwayepitheliumisaprimarysitefortherecognitionof
both viral and bacterial pathogens and initiates the host
defense against respiratory pathogens. Epithelial cells produce
chemokines and cytokines, such as interleukin-8 (IL-8), IL-6,
IL-1, granulocyte-macrophage colony-stimulating factor
(GM-CSF), and G-CSF, that function to recruit and activate
phagocytic cells to eradicate organisms and infected cells (1).
These mucosal epithelial cells are also a major source of the
type I interferons (alpha interferon [IFN-] and IFN-) that
are critical for viral clearance and coordinating immune regu-
lation (2). The role of type I IFNs in pulmonary defenses is
exempliﬁed by the increased susceptibility of mice lacking the
IFN-/ receptor to inﬂuenza virus infection and secondary
bacterialpneumonia(3).BacterialinductionoftypeIIFNshas
beenexaminedprimarilywithinthecontextofinfectiondueto
intracellular pathogens and limited to pathways expressed in
macrophages and dendritic cells (DCs) (4). These studies
indicate that the release of bacterial pathogen-associated mo-
lecular patterns (PAMPs) within the phagolysosome, from the
phagolysosomeintothecytosol(5),orfrombacteriawithinthe
cytosol also induces type I IFN responses, a situation which
closely mimics viral infection (6). However, there is little data
to indicate how nonphagocytic cells could produce type I IFNs
in response to extracellular bacteria, such as the organisms
which most commonly cause pneumonia.
The upper airway is the initial site of colonization by
S. pneumoniae. Aspiration of these organisms into the lower
airways induces a ﬂorid proinﬂammatory response ascribed to
the stimulation of Toll-like receptors (TLRs) on the surface of
airway and immune cells and activation of NF-B-dependent
signaling. S. pneumoniae produces a cholesterol-dependent,
pore-forming toxin, pneumolysin (Ply), which has inherent
proinﬂammatory activity (7) and is critical in pathogenesis
(8, 9). As autolysis and the release of cell fragments accompany
pneumococcal replication, the pneumolysin pore provides a
conduit for these PAMPs to gain access to the mucosal airway
cells (10). The presence of bacterial components, especially
DNA, within the cytosol is a potent stimulus for the type I
IFN cascade (11) that can be recognized by a number of re-
centlydescribedreceptors,includingRIG-1-likehelicases,DAI
(DNA-dependentactivatorofIFNregulatoryfactors),andsev-
eral others (6, 11–15). In the experiments described herein, we
demonstrate that pneumolysin and DNA are involved in the
activationoftypeIIFNsignaling,aresponsewhichcontributes
to pneumococcal clearance from the airway.
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S. pneumoniae induces expression of type I IFN genes in the
murine lung. To test the hypothesis that S. pneumoniae activates
type I IFN signaling, C57BL/6J mice were infected intranasally
with2107CFUofS.pneumoniaeD39for24handinductionof
Ifnb and other cytokine-encoding genes in lung tissue was
analyzed using quantitative reverse transcription (qRT)-PCR
(Fig. 1A). A 10-fold increase in Ifnb was observed in addition to
induction of the IFN--inducible genes Mx1, PKR, and LIF (16,
17). The chemokine KC (as a positive control) and the cytokine
IL-6 (also a type I gene product) were up-regulated by almost
1,000-fold. To document that these type I IFN-dependent genes
were induced through the expected JAK/STAT signaling cascade,
phosphorylationoftheSTAT1(P-STAT1)andSTAT3(P-STAT3)
transcription factors in the infected mouse lung tissues was dem-
onstrated and compared to a lipopolysaccharide (LPS) control
(Fig. 1B).
Pneumolysin contributes to induction of type I IFN signal-
inginvivoandinvitro.S.pneumoniaepneumolysinisreportedto
interact with TLR4 (7, 18), which interacts with TRIF (TIR
domain-containing adapter inducing IFN-) to participate in the
inductionoftypeIIFNsignaling.Recentdata(19)havesuggested
thattheimmuneresponsetopneumolysindoesnotinvolveTLR4.
PneumolysinalsofunctionsasaporethatallowsbacterialPAMPs
accesstotheepithelialcytosolandpathogenrecognitionreceptors
(10).WeassessedIfnbproductioninmice4hfollowingintranasal
infectionwith107CFUofwild-type(WT)S.pneumoniaeD39ora
ply null mutant. There was 40-fold induction of Ifnb by the WT
S. pneumoniae strain under these conditions but only a 3-fold
induction in mice infected with the ply mutant (P  0.029)
(Fig.2A).Atthis4-htimepoint,LIFandMx1wereexpressedand
this expression was pneumolysin dependent. Signiﬁcantly re-
duced levels of KC and IL-6 were also associated with exposure to
the ply mutant (P  0.001).
Despite equal numbers of WT and mutant bacteria in the lung
at this 4-h time point (Fig. 2B), there were signiﬁcant differences
in the immune cell populations. Pneumolysin expression was re-
quired for the recruitment of neutrophils, as the ply mutant and
thephosphate-bufferedsaline(PBS)controlattractedsimilarpro-
portions of neutrophils into the lung (Fig. 2C). Infection with the
ply null mutant resulted in the retention of a signiﬁcantly (P 
0.0002) larger percentage of CD11c cells (analogous to PBS
mice), representing macrophages and DCs, than did infection
with WT S. pneumoniae (Fig. 2D), which is consistent with the
idea that Ply is a major immunostimulant (7, 20, 21).
Toassessepithelialcellinvolvementinthesignalingofthetype
I IFN response, we tested the induction of Ifnb in murine airway
epithelial cells in primary culture. Murine airway epithelial cells
stimulatedwithS.pneumoniaehad10-foldinductionofIfnbat4h
compared with the 2-fold induction stimulated by the ply null
mutant (Fig. 2E). Ifnb induction in epithelial cells was not inhib-
itedbycytochalasinD,indicatingthatendocytosiswasunlikelyto
be involved in this signaling (Fig. 2F).
Pneumolysin-dependent pore formation is involved in in-
ductionoftypeIIFNsignaling.Theroleofporeformationinthe
stimulation of Ifnb was examined using a Ply W433F mutant, a
toxoid (PdB)-expressing strain in the S. pneumoniae P1121 back-
ground that has 0.1% of the WT hemolytic activity but is still
capable of binding and oligomerizing into cellular membranes
(22, 23). STAT1 phosphorylation in murine lungs exposed to the
S.pneumoniaetoxoid-expressingstrainwassubstantiallylessthan
that induced by the P1121 parent strain (Fig. 2G). We used ﬂuo-
rescent(AlexaFluor488[AF488]-labeled)Plytofollowthedistri-
bution of the toxin in polarized airway monolayers, which was
limited to the apical surfaces, consistent with a role as a pore
(Fig. 2H). Activation of Ifnb was not detected when puriﬁed re-
combinant Ply was applied to the cells (Fig. 2I), as a control for
signalingthatp38phosphorylationwasstilldetected(seeFig.S1in
thesupplementalmaterial).However,whenPlywasappliedinthe
presence of a ply pneumococcal cell lysate, a signiﬁcant increase
(P  0.045) in Ifnb induction was observed, but not with a toxoid
version of the protein (Fig. 2J and Fig. S2 in the supplemental
material shows that the toxoid has signiﬁcantly reduce hemolytic
activity). These results suggest that pneumolysin pore activity is
involvedinthedeliveryofaligandthatactivatestypeIIFNsignal-
ing.
Induction of Ifnb by S. pneumoniae is TLR4, MyD88, trif,
andNod2independent.Wenextexaminedwhichsignalingpath-
ways are involved in mediating pneumococcal activation of
IFN-. As it has been suggested that Ply functions as a TLR4 ago-
nist(7,18,24),wetestedtheparticipationofTLR4anditsadaptor
TRIF in mediating pneumococcal type I IFN signaling (Fig. 3).
C57BL/6J WT, Tlr4/, and Trif/ mice were intranasally inoc-
ulated with either PBS or 107 CFU of S. pneumoniae, and induc-
tionofIfnbandSTAT1phosphorylationwasexamined24hlater.
FIG 1 S. pneumoniae activates the type I IFN response in vivo. Mice were
infected with 2  107 CFU of S. pneumoniae and analyzed 24 h later. (A)
qRT-PCRoftypeIIFNandinﬂammatorycytokinegenesfromRNAextracted
frominfectedmouselungs.Graphsdisplaymeanswithstandarddeviations(n
 3). (B) Immunoblots of transcription factors P-STAT1 and P-STAT3 from
mouse lungs. -Actin was used as a loading control. Each lane represents an
individualmouse.Dataarerepresentativeoftwoexperiments.LPSfromE.coli
(50 g per mouse) was used as a positive control.
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increased levels of P-STAT1 (Fig. 3A and B) and Ifnb production
(3-foldhigherthanthoseoftheWT;Fig.3B),whichwerenotdue
to increased bacterial numbers in the lung (data not shown), as
has been reported by others (25). Trif/ mice were also able to
phosphorylate STAT1, indicating that endosomal TLR3 and
TLR4, which use Trif/Tram adaptors, are not involved in the re-
sponse to S. pneumoniae.
Type I IFN signaling through the other endosomal TLRs
(TLR7, TLR8, and TLR9) that utilize the adapter MyD88 (7) was
alsoexcluded.InresponsetoS.pneumoniae,MyD88/nullmice
had increased activation of STAT1 and Ifnb induction compared
to that of WT mice (Fig. 3A and B), consistent with increased
levels of infection (26).
We next screened for involvement of the cytosolic receptor
Nod2 (nucleotide-binding oligomerization domain 2), which
senses peptidoglycan (27) and can be transported via the pneu-
molysin pore (10, 28). Although a link between Nod2 and type I
IFN production has been observed (29–31), Nod2/ mice still
responded to S. pneumoniae (Fig. 3A and B).
Pneumococcal DNA activates IFN- expression. During ac-
tive growth, pneumococci spontaneously lyse, releasing cellular
components, including DNA. S. pneumoniae produces an autoly-
sin (LytA, an amidase) required for autolysis and release of cell
wall components (9). Incubation of epithelial cells with a lytA
strain of S. pneumoniae did not activate type I IFN signaling
(Fig. 4B), indicating that the inducing ligand is liberated from
lysed cells. DNA is a potent activator of type I IFN signaling, and
Ply could permit bacterial DNA to enter the cytosol, where it
would interact with one or more of the several different types of
DNAsensorsthatinducetypeIIFNsignaling(11).Pneumococcal
lysates incubated with DNase were found to stimulate signiﬁ-
FIG2 PneumolysinisinvolvedintheinductionoftypeIIFN.C57BL/6Jmicewereinfectedwith2107CFUofS.pneumoniae(S.p.)intranasallyandstudied
a t4h( At oD ) .( A )WT-infected lung data are shown in black, and ply mutant-infected lung data are shaded grey. *, P  0.05 (Student’s t test; n  8). Lung
homogenateswereanalyzedforbacterialcounts(B),neutrophils(percentageofLy6GLy6CCD45cells)(C),andCD11ccells(D)byFACS.Linesrepresent
median values. *, P  0.05 (WT versus ply mutant; Mann-Whitney test; n  8, except for the PBS controls). (E) Murine nasal epithelial cells in primary culture
were stimulated for the times indicated with WT or ply mutant S. pneumoniae D39 in the presence or absence of cytochalasin D (CytoD) (F). DMSO, dimethyl
sulfoxide.*,P0.05(Student’sttest;n3).(G)MicewereintranasallyadministeredS.pneumoniaestrains(P1121background)expressingWTpneumolysin,
no pneumolysin, or a nonhemolytic toxoid variant and examined 4 h later. Lung homogenates were immunoblotted for P-STAT1. Each lane represents an
individualmouse.(H)AF488-labeledpneumolysinisvisualizedinmurinenasalepithelialcellsat1hpoststimulation.Murineepithelialcellsinprimaryculture
followingstimulationwithS.pneumoniaeD39orpuriﬁedpneumolysin(Ply)(I)orwithplylysateswithandwithoutpuriﬁedpneumolysinorPdB(J).*,P0.05
comparedtounstimulatedcells(Student’sttest;n3).RNAwasextractedandanalyzedforlevelsofIFN-byqRT-PCR.Allgraphsdisplaymeanswithstandard
deviations.
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implicating pneumococcal DNA as the ligand. To further impli-
cate pneumolysin in enabling DNA entry into the epithelial cells,
we demonstrated increased amounts of pneumococcal DNA in
murine epithelial cells incubated with WT S. pneumoniae com-
pared to the ply mutant (Fig. 4C). However, reconstitution of the
systeminvitro,i.e.,addingpuriﬁedPlyandS.pneumoniaeDNAto
murine airway epithelial cells in primary culture, did not result in
Ifnb induction.
DAIparticipatesinsensingofpneumococcalDNA.Thereare
numerous receptors that respond to foreign DNA but relatively
fewthatdonotinvolveTLRs.DNAreceptorsthatstimulateIFN-
expression are available within both endosomes and the cytosol
(11). DAI is a cytosolic double-stranded DNA sensor that re-
sponds to DNA from several sources (32), although it has been
shown to be dispensable for DNA detection in cells isolated from
DAInullmice(33).InresponsetoS.pneumoniaeinthelung,there
was a signiﬁcant (15-fold, P  0.002) increase in DAI transcrip-
tion, consistent with its known induction by IFN- (32) and sug-
gestive of involvement in pneumococcal signaling (Fig. 5A).
Wetookadvantageofmacrophagecelllinesanddendriticcells
in primary culture to evaluate the participation of the expected
components of the DAI cascade in response to pneumococcal
DNA. To conﬁrm that pneumococcal DNA was a ligand in im-
munecells,weincubatedpneumococcallysatetreatedwithDNase
orRNasebeforestimulatingdendriticcells(Fig.5B).Weobserved
a signiﬁcant (90%, P  0.007) decrease in Ifnb induction in the
DNase-treated lysate. No loss of induction was observed in the
RNase-treated sample. The requirement for DAI in recognizing
pneumococcal DNA was conﬁrmed in DAI-deﬁcient macro-
phages (Fig. 5C). A signiﬁcant (50%, P  0.048) decrease in Ifnb
inductionwasobservedinDAI-deﬁcientcellscomparedtothatin
WTcontrols.Thiswasnotspeciﬁctojustpneumococcalgenomic
DNA, as DNA from Pseudomonas aeruginosa and Staphylococcus
aureus also stimulated reduced IFN- signaling in the DAI null
background (bone marrow-derived DCs) (see Fig. S3 in the sup-
plemental material; Fig. S4 with controls). We also investigated
theroleoftherecentlyidentiﬁedfactorSTING(stimulatorofIFN
genes) (14), which is essential for the recognition of non-CpG
intracellular DNA species (Fig. 5C). Transfection of bone
marrow-derived macrophages with pneumococcal DNA resulted
in a complete absence of Ifnb induction in the STING/ cells (P
 0.0001).
To conﬁrm that the expected distal components of the DNA-
sensing cascade were involved, we transfected pneumococcal
FIG 3 Induction of IFN- production by S. pneumoniae in mice with muta-
tions in TLR4, Nod2, and innate adapters. WT and Tlr4/, Trif/,
MyD88/, and Nod2/ mutant C57BL/6J mice were infected intranasally
with 107 CFU of S. pneumoniae and examined 24 h later. (A) Lung homoge-
nates were assayed for STAT1 phosphorylation. Each lane represents an indi-
vidual mouse. Shown are representative experiments. (B) Lung tissue was an-
alyzedforinductionofIFN-byqRT-PCR(n4,exceptforNod2/mutant
mice [n  6]).
FIG 4 S. pneumoniae DNA activates type I IFN production. (A) Murine nasal epithelial cells were stimulated for 4 h with pneumococcal lysate that had been
left untreated or treated with DNase. (B) Murine nasal epithelial cells were stimulated for 4 h with the WT or lytA mutant strain (n  3). IFN- induction was
assessedbyqRT-PCRandisdisplayedasfoldinductionoverthatinPBS-onlycontrols.(C)Murinenasalepithelialcellswerestimulatedfor4hwiththeWTand
plymutantstrains(n3).DNAwasextractedfromtheepithelialcells,andlevelsofS.pneumoniae16SrRNAweremeasuredbyqRT-PCR.Un,untreatedlysate.
*, P  0.05 compared to WT or untreated samples (Student’s t test). All results shown are representative of at least two independent experiments.
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nase1(TBK1)(inaTNFR1nullbackgroundsinceTBK1nullmice
areembryoniclethal[34,35])(Fig.5D)andIFNregulatoryfactor
3 (IRF3) (Fig. 5E) transcription factors, both of which were re-
quired for Ifnb induction, results consistent with the involvement
of DAI in the sensing of cytosolic DNA (15).
Participation of RIG-1, which stimulates helicase activity in a
complex with MAVS, resulting in IFN- expression through
TBK1 and IRF3 (12, 13), was excluded (Fig. 5F), as was signaling
through IRF5 (Fig. 5G) and IRF7 (Fig. 5H).
The signiﬁcance of DNA sensing in the context of live organ-
isms was also addressed. S. pneumoniae-induced Ifnb transcrip-
tion in bone marrow-derived cells from DAI/ mice was 50%
decreased (P  0.048) and that in cells isolated from STING/
mice was 40% decreased (P  0.0081) compared with that in
controls (Fig. 5I and J). Macrophage lines deﬁcient in TBK1 and
IRF3 displayed an even greater reduction of Ifnb induction
(Fig.5KandL),conﬁrmingtheparticipationoftheexpectedcom-
ponents of DAI-mediated IFN- signaling.
TypeIIFNsignalingcontributestoS.pneumoniaeclearance.
The physiological role of type I IFNs in the pathogenesis of pneu-
mococcalinfectionwasthenexploredbycomparingthecoloniza-
tion of WT mice with that of Ifnar/ mice. At 7 days postinocu-
lation of 129 SvEv mice infected intranasally with 107 CFU of
S. pneumoniae, Ifnar null mice had signiﬁcantly higher bacterial
counts(7-foldincrease,P0.0102)innasallavageﬂuidthanWT
controls(Fig.6A).Therewereincreasednumbersofmonocytesin
the lungs of infected Ifnar/ mice (Fig. 6B; 14% versus 9%, P 
0.0051)anddendriticcellpopulations(Fig.6C;4%versus1.6%,P
 0.0079) compared with the WT controls, consistent with the
known effects of type I IFN signaling on the mobilization of im-
mune cells to the lung (36). Neutrophil recruitment was equiva-
lent between WT and Ifnar/ mice (Fig. 6D). We did observe a
differenceinneutrophilsinFig.2C,butthiswasincellstakenatan
early time point from an intranasal infection, and pneumolysin
can activate cytokines other than type I IFNs (37, 38). We did not
observeadifferenceinbacterialnumbersinthelunginthismodel
(datanotshown),consistentwithotherstudies(39).Thus,despite
FIG5 PneumococcalDNAissensedbythecytosolicDAIsensor.(A)Micewereinfectedwith107CFUofS.pneumoniaeD39(S.p),andlungtissuewasanalyzed
for induction of DAI 24 h later (n  4). (B) Bone marrow-derived cells were stimulated with enzymatically treated S. pneumoniae lysates and then analyzed for
Ifnb production by qRT-PCR (n  3). (C) Bone marrow-derived cells from DAI/ (n  6) and STING/ (n  6) mice were transfected with pneumococcal
DNA,andIfnbinductionwasanalyzedbyqRT-PCR.IfnbinductionofpneumococcalDNA-stimulatedknockoutbonemarrow-derivedcellsandtheirrespective
controls downstream of DAI (D and E) and other type I signaling components (F to H) (n  3). Bone marrow-derived DCs and macrophages from DAI/ (I)
and STING/ (J) mice (n  6) and TBK1/ (K) and IRF3/ (L) mice (n  3) were stimulated with S. pneumoniae for 2 h, and Ifnb levels were quantitated
by qRT-PCR. Graphs display means plus standard deviations and are representative of two experiments (excluding STING data), and data are expressed as fold
induction compared to that of the control cell line stimulated with PBS alone. *, P  0.05 compared to unstimulated or WT samples (Student’s t test).
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signaling, there was increased colonization with S. pneumoniae.
DISCUSSION
In this report, we demonstrate the participation of airway epithe-
lialcellsintheinitialrecognitionofanimportantbacterialpatho-
gen, S. pneumoniae, in the respiratory tract. This immune re-
sponse is mediated by activation of the epithelial type I IFN
cascadebytheintracellularaccumulationofpneumococcalDNA.
As this pathway is readily activated by viral nucleic acids that ac-
cumulate in airway epithelial cells, it is not unexpected that bac-
terial nucleic acids could have a similar effect. The upper respira-
tory tract is continually exposed to commensal ﬂora, but the
bacterial components, including DNA released from lysed organ-
isms, do not appear to activate mucosal signaling. S. pneumoniae,
a pathogen, is distinct from commensal ﬂora by virtue of its ex-
pression of pneumolysin, the pore-forming toxin that enables li-
gandstogainaccesstotheepithelialcytosolandinitiatetypeIIFN
signaling. As the induction of proinﬂammatory responses in the
lung is so potentially deleterious to respiration, it seems logical
that mucosal signaling is activated only by PAMPs that are sensed
intracellularly, by organisms that have breached the barrier func-
tion of the airway mucosa. Our ﬁndings suggest that type I IFN
signaling may be a general host response to perceived cellular in-
vasion and does not discriminate among types of pathogens,
whetherviralorbacterial,butinsteadrespondstothenatureofthe
speciﬁc PAMPS within the cell.
In a model of nasopharyngeal colonization, the usual route of
pneumococcalinfection,thetypeIIFNresponseanalogoustothat
inducedbyinﬂuenzaviruscontributedtobacterialclearance.Pro-
ductionofpneumolysinseemstobecriticalintriggeringimmune
recognitionofS.pneumoniaeasapathogen.TheroleoftypeIIFN
signalinginthehostresponsetopneumococcalinfectionhasbeen
previously reported by Weigent et al. (40), who demonstrated
increasedsusceptibilitytoinfectioninmicetreatedwithanti-IFN-
/ antibodies. Mancuso et al. (41) similarly investigated the im-
portanceoftypeIIFNsignalinginS.pneumoniaesepsisandmen-
ingitismodels.Thesigniﬁcanceofnasopharyngealcolonizationin
the initiation of host defenses against S. pneumoniae was recently
highlighted in a microarray study that identiﬁed the induction of
a number of type I IFN-related genes in murine nasal lymphoid
tissue early in the course of a 6-week colonization (42). Less clear
is how necessary type I IFN induction is in the context of active
pneumococcal pneumonia, as models of pneumonia using direct
trachealinoculationoftheorganismsfailtodemonstrateanotable
phenotype (39). However, as upper airway colonization precedes
thedevelopmentofpneumonia,thisisacriticalstageinthepatho-
genesis of systemic pneumococcal infection.
It is increasingly apparent that the mucosal epithelium of the
lung provides much more than a physical barrier to infection but
activelyparticipatesinsensingandinitiatingimmunesignalingin
response to inhaled pathogens, both viral and bacterial. This sig-
naling includes not only the proinﬂammatory cascades set off by
the apically exposed TLRs but also intracellular sensing systems.
For at least two important pulmonary pathogens, S. aureus and
S. pneumoniae, shed components that are either endocytosed
(S. aureus protein A [36]) or taken up via pore formation (pneu-
molysin)triggerIFN-productioninbothepithelialandimmune
FIG 6 Type I IFN production contributes to pneumococcal clearance. WT and Ifnar/ mutant mice (129/SvEV background for both) were infected with
107 CFU of S. pneumoniae intranasally and examined 7 days later. Shown are bacterial counts recovered from nasal lavage ﬂuid samples (A) and percentages of
monocyticcells(percentageofCD11bCD45cells)(B),DCs(percentageofCD11bCD11cCD45cells)(C),andneutrophils(percentageofLy6GLy6C
CD45cells)(D)fromlunghomogenatesanalyzedbyFACS.Eachdatapointrepresentsanindividualmouse(n12).Dataarecombinedfromtwoindependent
experiments. Lines represent median values. *, P  0.05 compared to WT mice (Mann-Whitney test).
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bacteriatoaccessintracellularreceptorssuggestsacentralrolefor
the type I IFN cascade in mucosal defenses against respiratory
pathogens of all types.
The expression of pneumolysin is critical in the activation of
type I IFN signaling by S. pneumoniae. Pneumolysin has been
shown previously to facilitate the introduction of peptidoglycan
into host cells, as well as induce host signaling from osmotic
changes (28, 43). DNA from lysed commensal ﬂora in the upper
respiratory tract could potentially be immunostimulatory, if the
organisms were able to deliver it into mucosal cells. The data sug-
gest that pneumolysin facilitates entry of DNA via its pore forma-
tion. We observed the requirement for pneumococcal lysis and
release of pneumococcal DNA as an autolysin null strain was un-
abletoinducetypeIIFNsignaling.Wecouldobviatethisrequire-
ment artiﬁcially by transfection of DNA or exposing naturally
phagocytic DCs to cell lysates. This suggests that the ability to
access cytosolic receptors may also contribute signiﬁcantly to vir-
ulence. However, the addition of puriﬁed pneumolysin and DNA
did not activate signaling (data not shown). The inability to arti-
ﬁciallyrecapitulatethesystem invitroindicatesamissingcompo-
nent, alternative ligand, or stoichiometric effects necessary to ac-
tivate signaling.
Severaldiscretereceptorsinboththecytosolandendosomesof
the cells that make up the respiratory mucosa participate in type I
IFN signaling. Our data suggest that DAI, whose role in immune
signaling has been debated (15, 33), may be important in the re-
sponse to pneumococcal DNA and other bacterial DNA. There
was a signiﬁcant induction of DAI expression by S. pneumoniae
and a signiﬁcant requirement for DAI to induce Ifnb in response
to pneumococcal DNA. In addition, the contribution of other
potentialDNAsensorsandsignalingcomponents(MAVS,RIG-I,
andTLRs)wasspeciﬁcallyexcluded(althoughtherewasatrendto
reduced induction in the MAVS null background, suggesting a
limited role for RNA polymerase III [12, 13]). The expected
downstream components of this pathway, including the recently
identiﬁedSTING(stimulatorofIFNgenes),TBK1,andIRF3pro-
teins,werealsoshowntobeinvolvedintheinductionofIfnbinthe
contexts of both DNA and the whole organism.
Thereisagrowingliteraturedetailinghowbacterialpathogens
inducethetypeIIFNcascadeinmacrophages(6,30,44–47).This
report provides a second example of how an extracellular patho-
gen can activate type I IFN signaling, an intracellular response
(36).Wenowshowthatepithelialcellssimilarlyparticipateinthe
induction of type I IFN signaling. Exactly how the epithelial cells,
whicharenotactivelyphagocytic,arestimulatedtoexpressIFN-
in response to other types of airway pathogens remains to be es-
tablished. However, based upon our observations with the pneu-
mococcus, it seems likely that a general induction of type I IFN
signaling in the lung, including the airway mucosal cells, is an
important consequence of both bacterial and viral infections of
the lung.
MATERIALS AND METHODS
Bacterial strains. S. pneumoniae strains D39 (48), D39 ply (49), 1725
(P1121, a derivative of P833, a human carriage isolate [50]), 1726 (P1121
ply [10]), 1727 (P1121 ply plyW433F, a PdB toxoid-expressing strain
[28]), and D39 lytA (51) were grown on Trypticase soy agar (supple-
mented with erythromycin for D39 ply) or broth supplemented with
200 U/ml catalase (Worthington). Plate cultures were grown at 37°C in
the presence of carbon dioxide (5%). Escherichia coli strain BL21AI (In-
vitrogen),P.aeruginosaPAO1,andS.aureusUSA300weregrownat37°C
on LB. All chemicals were purchased from Sigma unless otherwise stated.
RNA analysis. RNA was isolated using the RNAqueous-4PCR kit
(Ambion) with DNase treatment. cDNA was made using the iScript Syn-
thesis Kit (Bio-Rad). qRT-PCR was performed using Power SYBR Green
PCR Master Mix in a StepOne Plus thermal cycler (Applied Biosystems).
Samples were normalized to -actin or glyceraldehyde 3-phosphate de-
hydrogenase levels (sense, 5= ACCACAGTCCATGCCATCAC 3=; anti-
sense, 5= TCCACCACCCTGTTGCTGTA 3=). 16S rRNA primers for
S. pneumoniae were 5= GCCTACATGAAGTCGGAATCG 3= (sense) and
5= TACAAGGCCCGGGAACGT 3= (antisense). Primers for mouse actin,
Ifnb, Mx1, PKR, LIF, KC, IL-6, and DAI have been described elsewhere
(32, 36, 52).
Protein puriﬁcation and labeling. E. coli BL21AI carrying pET29a/
pneumolysin or pneumolysin W433F (37, 53) was grown to mid-
exponential phase and induced with 1 mM isopropyl--D-
thiogalactopyranoside (IPTG) and 0.2% arabinose for3ha t37°C. Cells
were lysed using Bugbuster (Novagen) and sonication in the presence of
the HALT protease cocktail (Pierce). His-tagged protein was puriﬁed
from clariﬁed lysates with nickel-charged agarose resin using Poly-Prep
gravity ﬂow columns (Bio-Rad). Eluted protein was also passed through
an endotoxin removal column (Detoxi-Gel columns; Thermo Scientiﬁc).
When required, protein was concentrated to 2 mg/ml using Amicon cen-
trifugation columns and labeled with AF488 according to the manufac-
turer’s instructions (AF448 labeling kit; Molecular Probes-Invitrogen).
Hemolytic activity of proteins was conﬁrmed (see Fig. S2 in the supple-
mental material).
Confocal microscopy. AF488-labeled pneumolysin (25 g/ml) was
incubated with murine nasal epithelial cells in primary culture for 1 h.
Cells were washed three times in PBS and ﬁxed in 4% paraformaldehyde
beforebeingblockedin5%normalgoatserumwith0.3%TritonX-100to
permeabilize cells. Phalloidin conjugated to rhodamine was used to stain
actin. Imaging was performed on a Zeiss LSM 510 META scanning con-
focal microscope and analyzed using LSM Image Browser software (ver-
sion 4.2).
Cell culture. Mouse nasal epithelial cells grown polarized from septa
were isolated from the indicated strains of adult mice and grown as de-
scribed elsewhere (54). Cells were stimulated with 5  108 CFU/ml of
bacteria.Puriﬁedpneumolysinwasappliedtocellsataﬁnalconcentration
of 2 g/ml for 4 h. Experiments were performed with cytochalasin D at
20 M and included a 30-min preincubation of inhibitor before the or-
ganism was applied. Pneumococcal lysate experiments were performed
using 5 mg/ml of protein. S. pneumoniae lysates (1 mg/ml) were treated
with100U/mlDNase(Ambion)or25g/mlRNase(digestionveriﬁedby
gel electrophoresis) for2ha t37°C before heat inactivation at 70°C for
10 min. DCs and macrophages were generated from bone marrow iso-
latedfromfemursandtibias(fromDAIandSTINGnullmice).DCswere
cultured for 7 days in RPMI 1640 medium supplemented with 10% fetal
bovine serum (FBS), streptomycin, penicillin, and 20 ng/ml of GM-CSF
(PeproTech). Macrophages were grown in Dulbecco’s modiﬁed Eagle’s
medium with 10% FBS, ciproﬂoxacin, and 20% L929 supernatant. Im-
mortalized macrophages (from TBK1, IRF3, IRF5, IRF7, and MAVS null
mice)werepreparedasdescribedpreviously(55)andstimulatedwith4
107CFU/mlS.pneumoniae.Celltransfectionswerecarriedoutusingbac-
terialgenomicDNAataﬁnalconcentrationof2g/ml.DNAwasisolated
using the DNeasy kit (Qiagen), and transfections were performed for 6 h
using FuGENE according to the manufacturer’s instructions (Roche).
Mouse studies. Lung infections with S. pneumoniae were performed
using 6-week-old C57BL/6J mice. Nod2/ mice were obtained from
JacksonLaboratories(originallyfromRegeneronPharmaceuticals).Mice
were anesthetized with 100 mg/kg ketamine and 5 mg/kg xylazine and
intranasallyinoculatedwith2107to5107CFUoftheorganism.LPS
fromE.coli(50gpermouse)wasusedasacontrol.Colonizationstudies
were performed with Ifnar/ and WT 129/SvEV mice. Six- to 7-week-
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ﬂuorescence-activated cell sorter (FACS) analysis, red blood cells were
lysed from lung homogenates. Cells were suspended in PBS with 2% FBS
and stained with combinations of phycoerythrin-labeled anti-CD45
(Caltag Laboratories), ﬂuorescein isothiocyanate-labeled anti-Ly6G/
Ly6C (clone RB6-8C5; BD Biosciences-Pharmingen), PerCP-Cy5.5-
labeled anti-CD11b (M1/70; eBioscience), and allophycocyanin-labeled
anti-CD11c (N418; eBioscience) antibodies in the presence of 10% nor-
mal mouse serum and Fc block (2.4G2; BD Biosciences). Negative con-
trols were stained with relevant isotype-matched antibodies. Cells were
ﬁxed with 1% paraformaldehyde and analyzed on a FACScalibur (Becton
Dickinson) using CellQuest software (version 3.3; BD). Cells were gated
on their side and forward scatter and CD45 expression. Data were ana-
lyzed using WinMDI (version 2.8; Joseph Trotter). All mouse infections
wereperformedundertheguidelinesoftheInstitutionalAnimalCareand
Use Committee of Columbia University.
Western blotting. Phosphorylation of STATs was detected using
P-STAT1 (Y701; Abcam) and P-STAT3 (Y705; Cell Signaling Technol-
ogy) and normalized to -actin (Sigma), while phosphorylation of p38
was detected using P-p38 (T180/Y182; Cell Signaling Technology) and
normalized to total p38 (Cell Signaling Technology). All immunoblot
assays were followed by secondary antibodies conjugated to horseradish
peroxidase (Santa Cruz Biotechnology Inc.). Samples from at least two
individual mice were typically analyzed on two separate occasions. Pro-
tein separation, transfer, and immunoblotting were performed as previ-
ously described (36).
Statistics.Signiﬁcanceofdatathatfollowedanormaldistributionwas
determined using a two-tailed Student t test, and for data that did not
follow a normal distribution, a nonparametric Mann-Whitney test was
used. Statistics were performed with GraphPad Prism software.
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